+7 (495) 230-22-32

Moscow, Tvardovskogo 8 str. 1
Location map



About us Products Quality policy Pharmaceutical Production Contacts


HIV


"Did you know?"

  • Nikavir - the drug, which is not inferior to the effectiveness of foreign mates, but it has far fewer side effects. «Epidemiology and infectious diseases» №1 p. 43, 2001.
  • Finally, the published data on the use of Nikavir (Phosphazid) in the case of prevention of HIV infection among medical workers of the scientific practical magazine "HIV-infection and иммуносупресии"
  • There is always the problem of the use of drugs of this kind in pregnant women and children, applies in this case also highly active antiretroviral therapy and the application of the preparation Никавир again proves to be more easily portable, in comparison with other preparations.
  • The study of the effects of the application of the classical triad with antiretroviral therapy Phosphazid, lamivudine and EFV: portability and unwanted effects.
  • The use of Никавира, Lamivudine and EFV in the schemes of first-line combination therapy of HIV-infection.
  • Today, the problem of viral hepatitis with parenteral mechanism of transmission remains relevant. This is due to the persistence of a rather high level of morbidity 2.7 and 2,24 per 100 thousand population for acute viral hepatitis b and C соответственна;
  • Viscount Pharma plans to Initiate phase II trials in Thailand early 1999 with the phosphorated zidovudine derivative PHOSPHAZID are a potential once a day therapy for HIV infection and AIDS.




© LLC "AZT FARMA K.B.", 2003-2021

 

 

Publication of materials from the site of LLC "AZT FARMA K.B."

allowed only with reference to the source